Table 2.
CXCL12 | CXCR4 | CXCR7 | |||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
Low (n) | High (n) | P value | Low (n) | High (n) | P value | Low (n) | High (n) | P value | |
PT | 36 | 29 | 0.039 | 26 | 39 | 0.067 | 23 | 42 | 0.054 |
MT | 23 | 32 | 24 | 41 | 20 | 45 |
PT, primary tumor; MT, lymph node metastasis tumor.
CXCL12 | CXCR4 | CXCR7 | |||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
Low (n) | High (n) | P value | Low (n) | High (n) | P value | Low (n) | High (n) | P value | |
PT | 36 | 29 | 0.039 | 26 | 39 | 0.067 | 23 | 42 | 0.054 |
MT | 23 | 32 | 24 | 41 | 20 | 45 |
PT, primary tumor; MT, lymph node metastasis tumor.